v3.19.1
Condensed Balance Sheets - USD ($)
Dec. 31, 2018
Dec. 31, 2017
Assets    
Cash $ 6,471,375 $ 5,601,878
Accounts receivable 0 6,850
Prepaid expenses 145,424 67,496
Inventory 59,444 191,680
Other current assets 273,315 14,249
Total Current Assets 6,949,558 5,882,153
Other Assets    
Fixed assets, net 273,233 241,549
Total Assets 7,222,791 6,123,702
Current Liabilities:    
Accounts payable and accrued liabilities 974,583 848,214
Total Liabilities 974,583 848,214
Stockholders' Deficit    
Preferred stock, $0.0001 par value; 10,000,000 shares authorized; no shares issued or outstanding 0 0
Common stock, $0.0001 par value; 50,000,000 shares authorized; 7,422,642 and 3,923,027 shares issued and outstanding 742 392
Additional paid in capital 33,939,162 23,170,531
Accumulated deficit (27,691,696) (17,895,435)
Total Stockholders' Equity 6,248,208 5,275,488
Total Liabilities and Stockholders' Equity $ 7,222,791 $ 6,123,702
v3.19.1
Condensed Statements of Operations - USD ($)
12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Income Statement [Abstract]    
Revenue $ 6,174 $ 351,622
Cost of Goods Sold 0 172,782
Gross Profit 6,174 178,840
Operating Expenses    
Research and development 4,722,465 1,931,075
Sales and marketing 262,641 122,604
General and administrative 3,752,535 2,751,219
Impairment of inventory 287,541 0
Total operating expenses 9,025,182 4,804,898
Operating loss (9,019,008) (4,626,058)
Other Expenses    
Other income (expense) (777,253) (750,904)
Total other expenses (777,253) (750,904)
Loss from operations before income taxes (9,796,261) (5,376,962)
Provision for income taxes 0 0
Net Loss $ (9,796,261) $ (5,376,962)
Net loss per share - basic and diluted $ (2.17) $ (1.95)
Weighted average common shares - basic and diluted 4,504,873 2,756,956
v3.19.1
Condensed Statements of Cash Flows - USD ($)
12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Cash Flows from Operating Activities    
Net loss $ (9,796,261) $ (5,376,962)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 68,316 61,481
Common stock, options and warrants issued for services 1,367,762 1,002,957
Imputed interest on promissory notes 0 1,480
Amortization of debt discount 729,241 711,472
Impairment of inventory 287,541 0
Changes in operating assets and liabilities:    
Decrease/increase in accounts receivable 6,850 (6,850)
Increase in prepaid expenses (77,928) (67,497)
Increase in inventory (155,305) (151,574)
Increase in other assets (259,066) (3,714)
Increase in accounts payable and accrued liabilities 126,368 528,294
Net cash used in operating activities (7,702,481) (3,300,913)
Cash Flows from Investing Activities:    
Purchases of fixed assets (100,000) (7,862)
Net cash used in investing activities (100,000) (7,862)
Cash Flows from Financing Activities    
Proceeds from issuance of common stock 7,736,678 8,590,700
Repayment of notes payable 0 (50,000)
Proceeds from convertible notes 935,300 225,000
Net cash provided by financing activities 8,671,978 8,765,700
Net Increase in cash 869,497 5,456,925
Cash, beginning of period 5,601,878 144,953
Cash, end of period 6,471,375 5,601,878
Supplemental disclosures:    
Interest paid 40,085 0
Income tax paid 0 0
Supplemental disclosures of non-cash Items:    
Discount on convertible notes 587,541 225,000
Conversion of convertible notes and accrued interest $ 1,077,000 $ 1,726,079